메뉴 건너뛰기




Volumn 115, Issue 8, 2010, Pages 1475-1476

ADAMTS13 testing: Why bother?

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ENZYME INHIBITOR; FIBRIN; HYALIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

EID: 77950428327     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-01-262709     Document Type: Note
Times cited : (7)

References (10)
  • 1
    • 0037158606 scopus 로고    scopus 로고
    • Thrombotic microangiopathies
    • Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347(8):589-600.
    • (2002) N Engl J Med , vol.347 , Issue.8 , pp. 589-600
    • Moake, J.L.1
  • 2
    • 41749101957 scopus 로고    scopus 로고
    • Pathogenesis of thrombotic microangiopathies
    • Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol. 2008;3:249-277.
    • (2008) Annu Rev Pathol , vol.3 , pp. 249-277
    • Zheng, X.L.1    Sadler, J.E.2
  • 3
    • 0026048114 scopus 로고
    • Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group
    • Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991;325(6):393-397.
    • (1991) N Engl J Med , vol.325 , Issue.6 , pp. 393-397
    • Rock, G.A.1    Shumak, K.H.2    Buskard, N.A.3
  • 4
    • 77949903692 scopus 로고    scopus 로고
    • Survival and relapse in patients with thrombotic thrombocytopenic purpura
    • Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010;115(8):1500-1511.
    • (2010) Blood , vol.115 , Issue.8 , pp. 1500-1511
    • Kremer Hovinga, J.A.1    Vesely, S.K.2    Terrell, D.R.3    Lämmle, B.4    George, J.N.5
  • 5
    • 17144408687 scopus 로고    scopus 로고
    • FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay
    • DOI 10.1111/j.1365-2141.2005.05420.x
    • Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005;129(1):93-100. (Pubitemid 40524057)
    • (2005) British Journal of Haematology , vol.129 , Issue.1 , pp. 93-100
    • Kokame, K.1    Nobe, Y.2    Kokubo, Y.3    Okayama, A.4    Miyata, T.5
  • 6
    • 33746650438 scopus 로고    scopus 로고
    • Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo
    • DOI 10.1111/j.1538-7836.2006.02025.x
    • Shelat SG, Smith AG, Ai J, Zheng XL. Inhibitory auto-antibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo. J Thromb Haemost 2006;4(8):1707-1717. (Pubitemid 44144797)
    • (2006) Journal of Thrombosis and Haemostasis , vol.4 , Issue.8 , pp. 1707-1717
    • Shelat, S.G.1    Smith, P.2    Ai, J.3    Zheng, X.L.4
  • 7
    • 40849114959 scopus 로고    scopus 로고
    • ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
    • Peyvandi F, Lavoretano S, Palla R, et al. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica. 2008;93(2):232-239.
    • (2008) Haematologica. , vol.93 , Issue.2 , pp. 232-239
    • Peyvandi, F.1    Lavoretano, S.2    Palla, R.3
  • 8
    • 2542490269 scopus 로고    scopus 로고
    • Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and non-idiopathic thrombotic thrombocytopenic purpura
    • Zheng XL, Richard KM, Goodnough LT, Sadler JE. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and non-idiopathic thrombotic thrombocytopenic purpura. Blood. 2004;103(11):4043-4049.
    • (2004) Blood. , vol.103 , Issue.11 , pp. 4043-4049
    • Zheng, X.L.1    Richard, K.M.2    Goodnough, L.T.3    Sadler, J.E.4
  • 9
    • 0032569840 scopus 로고    scopus 로고
    • Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
    • DOI 10.1056/NEJM199811263392203
    • Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585- 1594. (Pubitemid 28536133)
    • (1998) New England Journal of Medicine , vol.339 , Issue.22 , pp. 1585-1594
    • Tsai, H.-M.1    Lian, E.C.-Y.2
  • 10
    • 30444461242 scopus 로고    scopus 로고
    • Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: Its correlation with development of renal failure
    • DOI 10.1182/blood-2005-03-1087
    • Ono T, Mimuro J, Madoiwa S, et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood. 2006;107(2):528-534. (Pubitemid 43076375)
    • (2006) Blood , vol.107 , Issue.2 , pp. 528-534
    • Ono, T.1    Mimuro, J.2    Madoiwa, S.3    Soejima, K.4    Kashiwakura, Y.5    Ishiwata, A.6    Takano, K.7    Ohmori, T.8    Sakata, Y.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.